Shukra Pharmaceuticals Limited (SHUKRAPHAR) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE551C01044
Key metrics
- Market Cap
- ₹2,290 Cr
- P/E Ratio
- 66.62
- EPS
- 0.78
- Book Value
- 2.05
- P/B Ratio
- 25.35
- ROE
- 24.55%
- ROCE
- 26.66%
- Debt / Equity
- 0.06
- Net Margin
- 38.88%
- Revenue Growth
- 74.08%
- Profit Growth
- 130.37%
- Dividend Yield
- 0.02%
- 52W High
- ₹65.26
- 52W Low
- ₹26.18
- Market Cap Band
- small cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Shukra Pharmaceuticals Limited
Shukra Pharmaceuticals Limited manufactures and markets pharmaceutical products in India and internationally. Its product portfolio includes macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti-tuberculosis, vitamin products, anti-allergics, corticosteroids, hyper and hypoglycemic, and other products, as well as antibiotics, such as penicillin and cephalosporin. The company was formerly known as Relish Pharmaceuticals Limited and changed its name to Shukra Pharmaceuticals Limited in August 2016. Shukra Pharmaceuticals Limited was incorporated in 1993 and is based in Ahmedabad, India.
- Headquarters
- Ahmedabad, India
- Promoter Holding
- 89.32%
The full Shukra Pharmaceuticals Limited analysis
Create a free account to open the complete SHUKRAPHAR deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.